Intas Pharmaceuticals Technographics

Discover the latest software purchases and digital transformation initiatives being undertaken by Intas Pharmaceuticals and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 8000 Intas Pharmaceuticals employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.

During our research, we have identified that Intas Pharmaceuticals has purchased the following applications: Microsoft Azure Cloud Services for Application Hosting and Computing Services in 2019, Microsoft 365 for Collaboration in 2015, SAP S/4 HANA for ERP Financial in 2020 and the related IT decision-makers and key stakeholders.

Our database provides customer insight and contextual information on which enterprise applications and software systems Intas Pharmaceuticals is running and its propensity to invest more and deepen its relationship with Microsoft , Amazon Web Services (AWS) , GoDaddy or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.

We have been analyzing Intas Pharmaceuticals revenues, which have grown to $2.23 billion in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Intas Pharmaceuticals intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.